PMID: 6407430Feb 1, 1983Paper

Effect of bepridil on the heart rate of the healthy subject. Correlation with plasma levels

Archives des maladies du coeur et des vaisseaux
J P KantelipJ F Pognat

Abstract

Bepridil, an antianginal agent similar in some of its properties to the calcium antagonists, causes a prolonged dose-dependent bradycardia in the dog. This study was undertaken to assess this effect in man. Seven volunteers were administered bepridil in 15 days' sequences separated by a three week interval. The doses were 200, 300 and 600 mg daily respectively. A 24 hour continuous ECG was recorded by the Holter method before each drug sequence and on the fifteenth days. The results were submitted for computerised analysis. The plasma concentrations of bepridil were measured on the 15th day before the ingestion of the morning dose, the half life of the product being about 3 days. After 15 days' therapy of bepridil 200 mg the plasma concentration was 0,23 +/- 0,04 microgram/ml and there was no change in heart rate. At the end of the 300 mg/day sequence, the plasma concentrations reached 0,39 +/- 0.07 microgram/ml and the heart rate fell significantly by 7,9 +/- 2,6%. After 600 mg daily; the mean plasma concentration was 0,82 +/- 0,10 microgram/ml and the fall in heart rate was 10,7 +/- 2,3%. There was an excellent correlation between the plasma concentration and the reduction in heart rate. This reduction is caused by an indirec...Continue Reading

Related Concepts

Related Feeds

Bradyarrhythmias

Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.